Drugs / Piperacillin/tazobactam
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03671967 | May 2019 → Jan 2027 expected | bacterial infectious disease | Rambam Health Care Campus | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | piperacillin-tazobactam | “Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections” NCT03671967 ↗ |